Langley, P. C. “Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors”. INNOVATIONS in Pharmacy, vol. 8, no. 2, May 2017, doi:10.24926/iip.v8i2.516.